AstraZeneca shares on European trading fell 9% after a late-stage trial of
WAINUA, a treatment for neurological disorders, failed to meet expectations.
2026-07-09
AstraZeneca shares on European trading fell 9% after a late-stage trial of
WAINUA, a treatment for neurological disorders, failed to meet expectations.